As of May 25
| -12.90 / -81.81%|
The 2 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +56.79% increase from the last price of 2.87.
The current consensus among 2 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.